February 8, 2017 - Episode 1

FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year

Now Viewing
EP. 1: FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year
EP. 2: FDA Approval Sought in ALL, Early 2017 GU Symposium Highlights, and New HHS Secretary Confirmed

Gina Columbus reports on an FDA approval and 2 priority reviews in bladder cancer, highlights from the 2017 European Cancer Congress, a European approval in lung cancer, and ASCO announces its Cancer Advance of the Year.

Related Content:

February 8, 2017
FDA Approval Sought in ALL, Early 2017 GU Symposium Highlights, and New HHS Secretary Confirmed